Molecular and Clinical Study of Cardiovascular Hormones

心血管激素的分子和临床研究

基本信息

  • 批准号:
    08044272
  • 负责人:
  • 金额:
    $ 4.8万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for international Scientific Research
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 无数据
  • 项目状态:
    已结题

项目摘要

Recent studies have shown that novel' cardiovascular hormones' may be implicated in various cardiovascular disorders such as hypertension and myocardial infarction. To further explore their roles, we studied the natriuretic peptide system, endothelin system, and renin-angiotensin system at the molecular level in clinical and experimental settings, including genetically engineered animal models.Endothelial production of C-type natriuretic peptide (CNP), possessing vasorelaxant and antiproliferative properties, was markedly increased through TGF-BETA activation under coculture with vascular smooth muscle cells (VSVC), and was significantly decreased by vascular endothelial growth factor or insulin. Furthermore, the G1 arrest was induced by adenovirus-mediated CNP gene transfer into VSMC,and CNP induced an antiproliferative homeobox Gax as opposed to the effect of angiotensinII.Thus, these Multiple mediators may be interacting locally in vascular remodeling, being potential targets for ca … More rdiovacular gene therapy. We also showed that transgenic mice overexpressing brain natriuretic peptide(BNP) exhibited significant hypotension with decreased cardiac mass, suggesting its cardioprotective effect. We further revealed that the BNP and ANP genes are organized in tandem in the mouse and humangenomes.We also revealed the presence of short nonfunctional forms of the endothelin-A receptor in various human tissues by alternative RNA splicing, suggesting a regulatory role in its gene expression.Angiotensin II type 2(AT_2) receptor was abundantly expressed in human myometrium and markedly down-regulated during pregnancy, suggesting its role in uterine function. In cultured rat mesangial cells, the AT_2 receptor was markedly induced upon confluency and exerted an antiproliferative effect, counteracting the AT_1 receptor. Lower expression of the AT_2 receptor in genetically hypertensive rat kidneys suggested its implication in pathogenesis of hypertension. Furthermore, in hypertensive transgenic rats overexpressing mouse renin (Ren-2), cardiac secretion of ANP and BNP upon stimulation was attenuated, suggesting its contribution to their cardiovascular complications. Less
最近的研究如何将塔维尔的心血管梗死'tavel's肌肉梗死。血管肌肉细胞(VSVC),并通过血管渗透性因子或胰岛素显着降低。心脏质量,SUGENT是心脏保护作用。在其基因表达中的作用。在人肌层和肌层中,培养基中有大量表达的血管紧张素II(AT_2)受体。 Recep Ottimend Rat肾脏暗示其在高表达小鼠肾脏(REN-2)的转基因大鼠的发病机理中,ANP和BNP的心脏秘密表明其对R心血管的贡献。

项目成果

期刊论文数量(46)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
K.Yamamoto,et al.: "Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy." Hypertension. 28. 988-994 (1996)
K.Yamamoto 等人:“脑钠肽作为心室收缩和舒张功能障碍以及心室肥厚的激素标志物的优越性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Nakao,et al.: "The natriuretic peptide family." Current Opinion in Nephrology and Hypertension. 5. 4-11 (1996)
K.Nakao 等人:“利尿钠肽家族。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M.Marttila,et al.: "Synthesis and secretion of natriuretic peptides in the hypertensive TGR(mREN-2)27 transgenic rat." Hypertension. 28. 995-1004 (1996)
M.Marttila 等人:“高血压 TGR(mREN-2)27 转基因大鼠中钠尿肽的合成和分泌”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M.Kotani,et al.: "Structural organization of the human prostaglandin EP3 receptor subtype gene." Genomics. (in press). (1997)
M.Kotani 等人:“人类前列腺素 EP3 受体亚型基因的结构组织。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.-H.Chun,et al.: "Shear stress augments expression of C-type natriuretic peptide and adrenomedullin." Hypertension. 29(in press). (1997)
T.-H.Chun 等人:“剪切应力增强了 C 型利钠肽和肾上腺髓质素的表达。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAKAO Kazuwa其他文献

NAKAO Kazuwa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAKAO Kazuwa', 18)}}的其他基金

Development and analysis of model rats for diseases of endocrinology and metabolism
内分泌代谢疾病模型大鼠的建立及分析
  • 批准号:
    23659476
  • 财政年份:
    2011
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Physiological Function of Hormones Derived from Mesenchymal Cells and Its Failure
间充质细胞激素的生理功能及其失效
  • 批准号:
    21229013
  • 财政年份:
    2009
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Translational research and development of novel diagnostic/therapeutic modalities for metabolic syndrome based on adipocyte endocrinology and adiposcience
基于脂肪细胞内分泌学和脂肪科学的代谢综合征新型诊断/治疗方式的转化研究和开发
  • 批准号:
    16109007
  • 财政年份:
    2004
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Molecular Basis of Centrally-controled Energy Homeostasis -Focusing on Leptin Resistance-
中央控制能量稳态的分子基础 - 关注瘦素抵抗 -
  • 批准号:
    13307033
  • 财政年份:
    2001
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Clinical implication of cardiovascular hormones
心血管激素的临床意义
  • 批准号:
    10307026
  • 财政年份:
    1998
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A).
Molecular Study on Physiological and Clinical Significance of Adrenomedullin
肾上腺髓质素生理和临床意义的分子研究
  • 批准号:
    10218204
  • 财政年份:
    1998
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
New Animal Models Of Leaness And Obesity by Genetic Engineering and its Application to Therapy
基因工程瘦和肥胖的新动物模型及其在治疗中的应用
  • 批准号:
    09557080
  • 财政年份:
    1997
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of novel mouse models deficient in vasoactive substances-Clinical implication of the natriuretic peptide family and its application to gene therapy-
血管活性物质缺乏的新型小鼠模型的开发-利尿钠肽家族的临床意义及其在基因治疗中的应用-
  • 批准号:
    07557072
  • 财政年份:
    1995
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular Biology of Vasoactive Substances
血管活性物质的分子生物学
  • 批准号:
    06404037
  • 财政年份:
    1994
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular biology of vasoactive substances
血管活性物质的分子生物学
  • 批准号:
    06044129
  • 财政年份:
    1994
  • 资助金额:
    $ 4.8万
  • 项目类别:
    Grant-in-Aid for international Scientific Research

相似国自然基金

肺血管结构重构调控的新机制:内源性硫化氢介导的内皮素A型受体过硫化修饰
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
内皮素受体EDNRB导致耳聋、听力损失的分子机制及药理学研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
内皮素B型受体信号通路在少突胶质细胞分化以及在脱髓鞘疾病治疗中的应用研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
周细胞内皮素受体在心肌缺血/再灌注冠脉微循环障碍中的作用及机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    51 万元
  • 项目类别:
    面上项目
LncRNA LINC02027通过SAFA蛋白调控内皮素-1表达并激活YAP/TAZ通路诱导肝细胞癌变的机制研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目

相似海外基金

Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition
ARB/NEP 抑制引起低血压反应的机制
  • 批准号:
    9884685
  • 财政年份:
    2020
  • 资助金额:
    $ 4.8万
  • 项目类别:
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition
ARB/NEP 抑制引起低血压反应的机制
  • 批准号:
    10186795
  • 财政年份:
    2020
  • 资助金额:
    $ 4.8万
  • 项目类别:
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition
ARB/NEP 抑制引起低血压反应的机制
  • 批准号:
    10456298
  • 财政年份:
    2020
  • 资助金额:
    $ 4.8万
  • 项目类别:
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition
ARB/NEP 抑制引起低血压反应的机制
  • 批准号:
    10620715
  • 财政年份:
    2020
  • 资助金额:
    $ 4.8万
  • 项目类别:
Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure
激活促胰液素受体作为治疗心力衰竭的策略
  • 批准号:
    9303747
  • 财政年份:
    2017
  • 资助金额:
    $ 4.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了